Bolt Biotherapeutics, Inc.
General ticker "BOLT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $8.4M (TTM average)
Bolt Biotherapeutics, Inc. does not follow the US Stock Market performance with the rate: -16.2%.
Estimated limits based on current volatility of 5.1%: low 6.18$, high 6.57$
Factors to consider:
- Total employees count: 23 (-55.8%) as of 2025
- Top business risk factors: Limited operating history, Need additional capital, Regulatory and compliance, Manufacturing scale up, Intellectual property risks
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.32$, 9.25$]
- 2026-12-31 to 2027-12-31 estimated range: [2.50$, 7.26$]
Financial Metrics affecting the BOLT estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Negative: Inventory ratio change, % of 22.65 > 4.15
- Negative: Industry earnings per price (median), % of -14.91 <= 0
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BOLT quotes
Long-term BOLT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7.88MM | $7.69MM | $7.70MM |
| Operating Expenses | $84.07MM | $80.74MM | $43.81MM |
| Operating Income | $-76.20MM | $-73.05MM | $-36.11MM |
| Non-Operating Income | $7.00MM | $9.93MM | $2.74MM |
| R&D Expense | $61.54MM | $57.47MM | $28.53MM |
| Income(Loss) | $-69.20MM | $-63.12MM | $-33.38MM |
| Net Income(Loss)* | $-69.20MM | $-63.12MM | $-33.38MM |
| Stockholders Equity | $112.74MM | $57.20MM | $26.50MM |
| Assets | $159.78MM | $99.63MM | $56.75MM |
| Operating Cash Flow | $-69.53MM | $-61.29MM | $-39.85MM |
| Capital expenditure | $0.21MM | $0.04MM | $0.07MM |
| Investing Cash Flow | $71.04MM | $57.58MM | $44.30MM |
| Financing Cash Flow | $0.25MM | $0.11MM | $0.02MM |
| Earnings Per Share** | $-36.59 | $-33.06 | $-17.85 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.